Despite a wavering market for digital health and the tech industry as a whole, venture capitalists, including those affiliated with health systems, continue to invest in promising health tech ideas.
Category: ROOT
$9M bailout possible for Mississippi hospital
The Leflore County (Miss.) Board of Supervisors agreed to contribute half of the $9 million it will take to complete the proposed takeover of the Greenwood (Miss.) Leflore Hospital by the University of Mississippi Medical Center, according to an Oct. 2…
Solera Health launches new women’s health network
Phoenix-based Solera Health launched a first-of-its-kind women’s health network, increasing accessibility to various services.
YouTube to extend verified healthcare source status to individual providers
Physicians, nurses and other healthcare professionals can apply to have their YouTube channels verified as a healthcare source in a push to limit misinformation on the site.
10 hospitals, health systems cutting jobs
Several hospitals and health systems are trimming their workforces or jobs due to financial and operational challenges.
Mark Premo on his chief data officer role at Providence
Renton, Wash.-based Providence recently promoted Mark Premo to chief data officer and group vice president.
Atlanta mayor seeks new operator to keep Wellstar AMC afloat
Atlanta Mayor Andre Dickens aims to keep Wellstar Atlanta Medical Center open — but first, the facility needs a new operator, Reporter Newspapers & Atlanta Intown reported Oct. 27.
Intermountain Healthcare gives $250K to Denver clinic catering to Latino community
Salt Lake City-based Intermountain Healthcare has handed over a $250,000 grant to a clinic in Denver that has historically served that city’s Latino community.
Oracle wants to create ‘global’ healthcare database, co-founder says
Larry Ellison, the co-founder and chief technology officer of Oracle, said he wants the company to create a global healthcare database, Diginomica reported.
Blood pressure drug recalled over cancer risk
For the fourth time this year, another drugmaker has recalled some of its products because of nitrosamines, which have been linked to cancer in animal trials.
